Naomi Y. Ko, MD MPH AM

Assistant Professor, Medicine

Naomi Ko
617.638.8188
FGH building, 1st floor, 820 Harrison Avenue

Biography

Breast Cancer
Cancer Disparities
Health Equity

Dr. Ko is an Assistant Professor of Medicine at Boston University School of Medicine (BUSM) and a medical oncologist at Boston Medical Center (BMC) who has a lifelong passion for social justice. After college, Dr. Ko participated in Teach For America followed by volunteer service at the Berkeley Free Clinic in the Bay Area. She went on to Johns Hopkins School of Medicine and School of Public Health to complete her MD MPH with a focus on health outcomes research for vulnerable populations. After internal medicine residency at Brigham and Women’s Hospital she arrived for fellowship in hematology/oncology at BUSM/BMC, which allowed Dr. Ko to conduct research in the context of caring for an underserved population within a large safety net institution. She has sought out meaningful projects that are a culmination of her passion for oncology, service to the underserved, and academic research. Her research has a translational focus that has been directed to understanding the disconnect between scientific discoveries in cancer treatment and delivery of evidence-based treatment to vulnerable, racial/ethnic minority women with breast cancer. She is actively investigating how tumor biology, poverty, communication and treatment influence breast cancer outcomes in diverse breast cancer populations.

Other Positions

  • Member, BU-BMC Cancer Center, Boston University
  • Member, Center of Excellence in Women’s Health, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Johns Hopkins University School of Medicine, MD
  • Johns Hopkins University School of Public Health, MPH
  • Harvard University, AM
  • Barnard College, BA

Publications

  • Published on 2/28/2022

    Calip GS, Nabulsi NA, Hubbard C, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D, Ko NY, Hoskins KF, Law EH. Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer. Cancer Causes Control. 2022 May; 33(5):793-799. PMID: 35226243.

    Read at: PubMed
  • Published on 11/19/2021

    Mukand NH, Ko NY, Nabulsi NA, Hubbard CC, Chiu BC, Hoskins KF, Calip GS. The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women. Breast Cancer. 2022 Mar; 29(2):287-295. PMID: 34797467.

    Read at: PubMed
  • Published on 11/12/2021

    LeClair AM, Battaglia TA, Casanova NL, Haas JS, Freund KM, Moy B, Parsons SK, Ko NY, Ross J, Ohrenberger E, Mullikin KR, Lemon SC. Assessment of patient navigation programs for breast cancer patients across the city of Boston. Support Care Cancer. 2022 Mar; 30(3):2435-2443. PMID: 34767089.

    Read at: PubMed
  • Published on 8/13/2021

    Zhou J, Cueto J, Ko NY, Hoskins KF, Nabulsi NA, Asfaw AA, Hubbard CC, Mitra D, Calip GS, Law EH. Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race. Breast. 2021 Oct; 59:367-375. PMID: 34419726.

    Read at: PubMed
  • Published on 7/9/2021

    Yan CH, Coleman C, Nabulsi NA, Chiu BC, Ko NY, Hoskins K, Calip GS. Associations between frailty and cancer-specific mortality among older women with breast cancer. Breast Cancer Res Treat. 2021 Oct; 189(3):769-779. PMID: 34241741.

    Read at: PubMed
  • Published on 7/1/2021

    Zhou J, Sweiss K, Han J, Ko NY, Patel PR, Chiu BC, Calip GS. Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma. JAMA Netw Open. 2021 07 01; 4(7):e2118410. PMID: 34313746.

    Read at: PubMed
  • Published on 3/1/2021

    Hoskins KF, Danciu OC, Ko NY, Calip GS. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women. JAMA Oncol. 2021 03 01; 7(3):370-378. PMID: 33475714.

    Read at: PubMed
  • Published on 2/23/2021

    Chen K, Abbassi M, Ko NY. A Shock-Like Pain and Inability to Ambulate: Thoracic Spinal Cord Compression from Hepatocellular Carcinoma. Case Rep Oncol. 2021 Jan-Apr; 14(1):56-61. PMID: 33776682.

    Read at: PubMed
  • Published on 1/15/2021

    Zhou J, Sweiss K, Nutescu EA, Han J, Patel PR, Ko NY, Lee TA, Chiu BC, Calip GS. Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO Oncol Pract. 2021 03; 17(3):e294-e312. PMID: 33449809.

    Read at: PubMed
  • Published on 1/1/2021

    Poulson MR, Beaulieu-Jones BR, Kenzik KM, Dechert TA, Ko NY, Sachs TE, Cassidy MR. Residential Racial Segregation and Disparities in Breast Cancer Presentation, Treatment, and Survival. Ann Surg. 2021 01 01; 273(1):3-9. PMID: 32889878.

    Read at: PubMed

View 43 more publications: View full profile at BUMC

View all profiles